EPI-001, a Bisphenol A diglicycyl ether (BADGE) derivative, was identified as a specific inhibitor of the AR that bound covalently to an undetermined structural motif in the AR NTD and inhibited the growth of androgen sensitive PCa and CRPC cells in vitro and in vivo [20, 21]. The gene discussed is AR; the disease is posterior cortical atrophy.